Compare Synchrony Financial (SYF) vs TransMedics Group Inc (TMDX) Price & Performance

Synchrony FinancialTrade

TransMedics Group IncTrade

Price performance (Past 24H)

Key statistics

Synchrony Financial vs TransMedics Group Inc — how do they compare? Synchrony Financial trades at $71.7 (market cap $24.69B), while TransMedics Group Inc trades at $74.3 (market cap $2.54B). The key difference: Synchrony Financial is far larger — about 9.7× TransMedics Group Inc's market cap, and Synchrony Financial pays a 1.63% dividend while TransMedics Group Inc pays none. Which is the better fit depends on your goals.

	SYF	TMDX
Market Cap	$24.69B	$2.54B
Sector	Financials	Technology
52-Week High	$88.47	$150.42
52-Week Low	$63.78	$61.99
Dividend Yield	1.63%	—
Enterprise Value	—	$2.94B

View details →View details →

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

SYF

Synchrony Financial shares fall despite strong loan growth and attractive dividends.Seeking Alpha · 5 hours agoBullish Consumers keep spending frequently despite inflation, boosting Synchrony's Q2 purchase volume 8%.PYMNTS · 9 hours agoBullish Synchrony Financial declares $0.34 quarterly dividend per common share, payable August 17, 2026.PRNewsWire · 17 hours agoNeutral View details →

TMDX

TransMedics to report Q2 2026 financial results on August 4 with a live conference call.PRNewsWire · 7 hours agoNeutral Atlas Healthcare Fund's 2020 Eli Lilly bet soared 246%, showcasing early clinical insight in healthcare investing.Vst Capital · 4 days agoBullish View details →

About Synchrony Financial

Synchrony Financial is a premier consumer financial services company and the largest provider of private-label credit cards in the United States. Spun off from GE Capital in 2014, it operates through a unique B2B2C model, embedding its financing products within the ecosystems of major partners like Amazon, Lowe’s, and PayPal. Synchrony leverages deep data analytics and a diverse multi-platform strategy—spanning retail, health, and auto—to drive customer loyalty and provide specialized credit solutions at the point of sale.

About TransMedics Group Inc

TransMedics is a pioneering medical technology company that is disrupting the organ transplant market with its Organ Care System (OCS™). By replacing traditional cold storage with portable warm perfusion, the OCS maintains donor organs in a near-physiologic state, allowing for continuous assessment and optimization. Through its National OCS Program (NOP™), TransMedics provides an end-to-end clinical and logistics solution, including a dedicated aviation fleet, to maximize the utilization of donor organs and improve patient outcomes.